Log in
Log in

  • Home
  • CPHA: The value of unfunded vaccines and the challenge in implementation

CPHA: The value of unfunded vaccines and the challenge in implementation

  • 10 Dec 2020
  • 4:00 PM - 4:55 PM
  • Webinar

Canadian Public Health ASsociation 

CIC 2020 Accredited Co-developed Learning Opportunity

 The value of unfunded vaccines and the challenge in implementation

There are life-saving vaccines available in Canada that are licensed, proven to be efficacious, but they are also unfunded and therefore underutilized. There are significant challenges related to awareness acceptability, and resultant proactive recommendation for immunization with unfunded vaccines. Healthcare providers are challenged with overcoming the perception that unfunded vaccines are less important, navigating conflicting information between product labels versus recommendations, and integration of unfunded vaccines within complex patient pathways.

The challenges of unfunded vaccines will continue to be a problem in the future as a growing number of vaccines will move from the pipeline to the Canadian market. Furthermore, these unfunded vaccines may never have public programs that cover all individuals at risk. In the absence of clear guidelines for how healthcare providers should manage and discuss these vaccines in their practice, patients will remain susceptible to vaccine-preventable diseases. How can the Canadian immunization community rise to meet this challenge?

Learning Objectives

  • Describe the value of unfunded vaccines and the need for greater awareness of what vaccines are available to address existing vaccine-preventable diseases.
  • List the gaps surrounding the use of unfunded vaccines in Canada, including challenges in the patient pathway, the current system of developing recommendations, and barriers to implementing recommendations in practice, and review how these challenges can be addressed by healthcare providers.
  • Outline avenues to better integrate unfunded vaccines into clinical practice across Canada.
  • Discuss ways to mitigate future challenges with a growing vaccine pipeline spanning the age spectrum, in order to create better access to unfunded vaccines.

  • Ajit Johal, Clinical Instructor, Faculty of Pharmaceutical Sciences, University of British Columbia; Founder and Clinical Director,
  • Joan Robinson, Professor and Divisional Director, Department of Paediatrics, Division of Paediatric Infectious Diseases, University of Alberta

This program was co-developed with AMMI Canada and GSK and was planned to achieve scientific integrity, objectivity and balance.

This session will be offered in English only. 

Register Here

Copyright 2017 - Public Health Physicians of Canada  /  Médecins de santé publique du Canada

Site by Merge Creative Inc.

Powered by Wild Apricot Membership Software